Found 0 matching trials
Is the 3D-PANC MSP Model Superior to CT for Assessing Response to Neoadjuvant Treatment in PCA Patients?
N/AProspective multicenter study in which all patients with borderline or loca...
Location
Hospital General de Alicante
Exploring Buckwheat's Glucose Lowering Potential
N/ABioactive components in buckwheat enhance insulin sensitivity in Type 2 dia...
Location
I.H. Asper Clinical Research Institute
Is Botox Effective in Relieving Pain From Knee Osteoarthritis?
PHASE1Patients with painful knee osteoarthritis will be randomly allocated to one...
Pericapsular Nerve Group (PENG) Block Versus Lumbar Erector Spinae Plane Block
PHASE2assess and compare the efficacy of pericapsular nerve group block wersus lu...
Location
Aculty of Medicine,Zagazig University
Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia
PHASE3The purpose of this study is to confirm the clinical efficacy and the safet...
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
PHASE2Primary Objective:
To assess the efficacy of SAR339658
Secondary Objectiv...
Location
Investigational Site Number 840065
Postoperative Analgesia After Minithoracotomy
PHASE4Patients scheduled for minimally invasive mitral valve replacement. Each pa...
Location
Queen Jadwiga Hospital
Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD)
PHASE1A Double-Masked, Randomized, Placebo-Controlled Study of the Safety, Tolera...
Status
Active Not Recruiting
Location
Beverly Hills Institute of Ophthalmology
Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy Subjects
PHASE1The purpose of this study is to evaluate the safety and pharmacokinetics of...
Location
Clinical Research Unit
To Assess Safety, Tolerability and Pharmacokinetics of BI 730357 in Healthy Male Volunteers
PHASE1The primary objective of the Single Rising Dose (SRD) part (trial part 1) i...
Location
Humanpharmakologisches Zentrum Biberach